Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians
David Massicotte‐Azarniouch(Ottawa Hospital), Michael Walsh(Population Health Research Institute), Mats Junek(St. Joseph’s Healthcare Hamilton), Priscilla Karnabi(Ottawa Hospital), Mark Canney(University of Ottawa), Nataliya Milman(University of Ottawa), Rachel Jones(University of Cambridge), David Jayne(University of Cambridge), Christian Pagnoux(Mount Sinai Hospital), Vimal K. Derebail(University of North Carolina at Chapel Hill), Peter A. Merkel(University of Pennsylvania), Ruth J. Pepper(University College Hospital), Alan D. Salama(The Royal Free Hospital)
Cited by 4
Related Papers
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|Arthritis & Rheumatism|2012|6.6k
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
|New England Journal of Medicine|2010|1.7k
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|UNC Libraries|2020|1.3k
Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis
|Journal of the American Society of Nephrology|2007|1.1k